Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Health Canada approves ipilimumab

Feb. 8, 2012

Health Canada accepts CIP-Isotretinoin submission for review

Jan. 31, 2012

Health Canada grants priority review status to Cinryze

Jan. 16, 2012

Abilify approved in Canada for use in new patient population

Dec. 21, 2011

Health Canada approves treatment for iron deficiency anemia in CKD

Dec. 13, 2011

Immunovaccine clear to start phase I/II DPX-Survivac trial in Canada

Oct. 27, 2011

Cytonet expands SELICA III study to Canada

Oct. 24, 2011

Health Canada approves single-pill combination drug for hypertension

Sep. 30, 2011

Health Canada issues new approval for Lucentis

Sep. 19, 2011

First triptan for migraine in adolescents approved in Canada

Sep. 12, 2011

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...